Dr Jenny Liu
People_

Dr Jenny Liu

Clinical Lecturer
Westmead Hospital / Faculty of Medicine and Health
Dr Jenny Liu

Dr Jia (Jenny) Liu (MD PhD) is a medical oncology staff specialist at The Kinghorn Cancer Centre, St Vincent's Hospital (Darlinghurst, Sydney Australia) specialising in head and neck cancer and early phase clinical trials.

She graduated from UNSW with BMed MD with the University Medal, and completed her PhD in 2011 on colorectal cancer epigenetics. She has maintained an active research portfolio concurrent to full time clinical training over the past decade. She is a honorary researcher at the Garvan Institute and visiting scientist at the Children's Medical Oncology (ProCan) group, where she is liaising with collaborators nationally and internationally to utilise a novel high throughput mass spectromety pipeline which accurately measures tumour tissue proteomes to identify signatures associated with treatment response and outcome in multiple cancer cohorts.

She has active research interests in supportive care including the development of novel interventions to address fear of cancer research in cancer survivors, and translational research to identify biomarkers to improve treatment prediction and prognostication.

Early phase clinical trials

Head and Neck Cancer

Lung Cancer

Breast Cancer

Prognostic and Predictive Biomarkers

Supportive Care Research

Clinical and Communications Skills

Use of technology in medical education

Clinical Trials and Research Skills

Brief Clinician Intervention to address Fear of Recurrence in Breast Cancer Survivors

Circulating tumour DNA in Stage III NSCLC

PD-L1 expression as a prognostic biomarker in EGFR NSCLC

Proteomics and multiomics in diverse cancer cohorts as predictive and prognostic signatures

Grants:

2021 Sydney Local Health District Implementation Grant

2020 Blacktown Hospital Kickstarter Grant

2019 Astra Zeneca Investigator Grant

2018 Sydney Breast Cancer Foundation Research Grant

2018 AVANT Trainee Research Scholarship

2018 Medical Oncology Group of Australia Best Poster by Trainee Award and Travel Grant

2018 Sydney Catalyst Rob Sutherland Travel Grant

2015 Scholarship to attend BSOC, Faculty of Medicine UNSW

2014 Finalist in RPA Patron's Prize

2013 UNSW Medicine University Medallist, Max Thorpe Prize for Best Overall Performance POWH Clinical School

2012 Dean's List Award for Outstanding Contribution to medical research UNSW

2011 Winner - Open Senior Division, Coast Association TOW Research Awards, POWH

2011 Winner - UNSW 3 minute thesis competition

2011 Oral Presentation Award, International conference on science of nutrition in medicine and healthcare

2011 Winner NHMRC Student Research Competition

2011 Oral Presentation Prize, Australian Epigenetics Alliance

2011 Cancer Institute NSW PhD Top Up Scholarship (Research Scholar's Award)

2010 Poster Prize, Coast Association TOW Research Awards

2009 Poster Prize, St Vincent's and Mater Health Research Symposium

Project titleResearch student
Investigating the Utility of Using Proteomics for Clinical Based Cancer ApplicationsEmma BOYS

Publications

Journals

  • Pham, J., Rodrigues, A., Goldinger, S., Sim, H., Liu, J. (2024). Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis. Experimental Dermatology, 33(1), e14978. [More Information]
  • Nindra, U., Shivasabesan, G., Mellor, R., Chua, W., Ng, W., Karikios, D., Richards, B., Liu, J. (2024). Evaluating Systemic Burnout in Medical Oncology Through a National Oncology Mentorship Program. JCO Oncology Practice, 20(4), 549-557. [More Information]
  • Liu, J., He, S., Butow, P., Shaw, J., McHardy, C., Harris, G., Serafimovska, A., Butt, Z., Beith, J. (2023). A novel clinician-delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2). Psycho-Oncology, 32(12), 1930-1938. [More Information]

2024

  • Pham, J., Rodrigues, A., Goldinger, S., Sim, H., Liu, J. (2024). Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis. Experimental Dermatology, 33(1), e14978. [More Information]
  • Nindra, U., Shivasabesan, G., Mellor, R., Chua, W., Ng, W., Karikios, D., Richards, B., Liu, J. (2024). Evaluating Systemic Burnout in Medical Oncology Through a National Oncology Mentorship Program. JCO Oncology Practice, 20(4), 549-557. [More Information]

2023

  • Liu, J., He, S., Butow, P., Shaw, J., McHardy, C., Harris, G., Serafimovska, A., Butt, Z., Beith, J. (2023). A novel clinician-delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2). Psycho-Oncology, 32(12), 1930-1938. [More Information]
  • Nindra, U., Hurwitz, J., Forstner, D., Chin, V., Gallagher, R., Liu, J. (2023). A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma. Cancer Medicine. [More Information]
  • Boys, E., Liu, J., Robinson, P., Reddel, R. (2023). Clinical applications of mass spectrometry-based proteomics in cancer: Where are we? Proteomics, 23(2023-08-07 00:00:00). [More Information]

2022

  • Cai, Z., Poulos, R., Liu, J., Zhong, Q. (2022). Machine learning for multi-omics data integration in cancer. iScience, 25(2), 103798. [More Information]

2021

  • Serafimovska, A., Liu, J., Beith, J., Butow, P. (2021). Patients' and oncologists' perspectives on a novel Clinician-led Fear of Cancer Recurrence (CIFeR) Intervention. Supportive Care in Cancer, 29(12), 7637-7646. [More Information]
  • Liu, J., Itchins, M., Nagrial, A., Cooper, W., De Silva, M., Barnet, M., Varikatt, W., Sivasubramaniam, V., Davis, A., Gill, A., Blinman, P., Lee, K., Hui, R., Pavlakis, N., Clarke, S., Boyer, M., Kao, S., et al (2021). Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors. Lung Cancer, 155, 28-33. [More Information]

2020

  • Liu, J., Wong, K., Patanjali, N., Boyer, M., Kao, S. (2020). Case of post-progression prolongation of survival after cessation of pembrolizumab in advanced non-small-cell lung cancer. Internal Medicine Journal, 50(6), 771-773. [More Information]
  • Liu, J., Goel, S., Beith, J. (2020). Trastuzumab-related cardiotoxicity: What do we know in 2020? Translational Cancer Research, 9(7), 4052-4055. [More Information]

2019

  • Goel, S., Liu, J., Guo, H., Barry, W., Bell, R., Murray, B., Lynch, J., Bastick, P., Chantrill, L., Kiely, B., et al (2019). Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity. JACC: Heart Failure, 7(9), 795-804. [More Information]
  • Liu, J., Butow, P., Beith, J. (2019). Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors. Supportive Care in Cancer, 27(11), 4055-4067. [More Information]

2017

  • Crabtree, N., Mo, S., Ong, L., Jegathees, T., Wei, D., Fahey, D., Liu, J. (2017). Retrospective Analysis of Patient Presentations at the Sydney (Australia) Royal Easter Show from 2012 to 2014. Prehospital and Disaster Medicine, 32(2), 187-194. [More Information]

2016

  • Liu, J., Ng, D., Lee, J., Stalley, P., Hong, A. (2016). Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy. Radiation Oncology, 11(1), 1-6. [More Information]

2015

  • Liu, J., Zhang, M., Rose, B., Veillard, A., Jones, D., Zhang, X., Lee, C., Milross, C., Hong, A. (2015). Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma. Annals of Surgical Oncology, 22(6), 1893-1900. [More Information]

Twitter: @JiaJennyLiu